Description
Telma-Beta 50 Tablet ER is a combination antihypertensive medicine that provides enhanced blood pressure control through:
-
Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure.
-
Metoprolol Succinate (50mg ER): A beta-blocker that reduces heart rate and cardiac workload, contributing to sustained blood pressure management.
The extended-release (ER) formulation ensures consistent 24-hour effect, making it ideal for patients requiring strong and continuous hypertension control.
Uses of Telma-Beta 50 Tablet ER
-
Management of high blood pressure (hypertension)
-
Reduction of cardiovascular risks such as heart attack and stroke
-
Control of tachycardia or elevated heart rate in hypertensive patients
-
Suitable for patients needing dual-action therapy (ARB + beta-blocker)
How to Take
-
Take once daily, preferably at the same time each day.
-
Can be taken with or without food.
-
Swallow the tablet whole; do not crush or chew the ER tablet.
-
Do not adjust or stop dosage without your doctor’s guidance.
Side Effects
Common:
-
Dizziness or lightheadedness
-
Fatigue
-
Slow heart rate (bradycardia)
-
Cold hands or feet
Serious (rare):
-
Severe hypotension
-
Worsening of heart failure in predisposed patients
-
Allergic reactions (rash, swelling, breathing difficulty)
Precautions & Warnings
-
Prescription Required
-
Not recommended during pregnancy or breastfeeding.
-
Use cautiously in patients with heart failure, asthma, or kidney/liver disease.
-
Monitor blood pressure, heart rate, and kidney function regularly.
-
Avoid abrupt discontinuation of beta-blockers to prevent rebound hypertension or cardiac complications.
-
Inform your doctor about all other medications, especially other antihypertensives or heart medications.
Conclusion
Telma-Beta 50 Tablet ER (Telmisartan 40mg + Metoprolol Succinate 50mg ER) offers dual-action, extended-release therapy for effective 24-hour management of hypertension. It is especially suitable for patients requiring stronger cardiovascular protection through combined ARB and beta-blocker effects, under strict medical supervision.
Leave a Reply